Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Risks and Benefits of Taxanes in Breast and Ovarian Cancer

By Michaud L.B.  

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 401-428

Adis International

Access to resources Recommend Favorite

Costs of taxanes, capecitabine, quantified for breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?

By Nabholtz J-M.   Tonkin K.   Smylie M.   Au H-J.   Lindsay M-A.   Mackey J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 187-206

Informa Healthcare

Access to resources Recommend Favorite

Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer

By Choy Hak   Pyo Hongryull   Kim Jae-sung   MacRae Rob  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 963-974

Informa Healthcare

Access to resources Recommend Favorite